Cambrex Corporation is an innovative life sciences company providing products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. We offer a variety of technology-driven products and services for generic and branded pharmaceuticals: APIs, advanced intermediates, drug delivery products, custom development and manufacturing. Our R&D and cGMP manufacturing facilities are located in the US, Europe and India. We are committed to operating our facilities with the highest standards of regulatory compliance and environmental, health and safety guidelines. Cambrex Corporation is headquartered in East Rutherford, NJ, USA and is listed on the NYSE (CBM).